Skip to Content

West Nile - Innovator

This page contains information on West Nile - Innovator for veterinary use.
The information provided typically includes the following:
  • West Nile - Innovator Indications
  • Warnings and cautions for West Nile - Innovator
  • Direction and dosage information for West Nile - Innovator

West Nile - Innovator

This treatment applies to the following species:
Manufacturer: Zoetis

West Nile Virus Vaccine

Killed Virus

West Nile - Innovator Indications

For intramuscular vaccination of healthy horses 10 months of age or older as an aid in the prevention of viremia caused by West Nile Virus. Efficacy was demonstrated in horses that received two doses of the vaccine and were challenged one year post-vaccination with West Nile Virus. The vaccine protected 95% of the vaccinates against viremia, while 82% of the controls were viremic.

DOSE: Inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 6 weeks after the first dose. Revaccinate annually with one 1 mL dose.

West Nile - Innovator Caution

Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.

Thimerosal, neomycin and polymyxin B added as preservatives.

For Veterinary Use Only

U.S. Vet. License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

1 mL

1 Dose


10 mL

10 Doses

NAC No.: 3690342.3

Telephone:   269-359-4414
Customer Service:   888-963-8471
Every effort has been made to ensure the accuracy of the West Nile - Innovator information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2015 North American Compendiums. Updated: 2015-11-23